SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: tonyt who wrote (14334)2/6/1998 9:05:00 AM
From: Arthur Radley  Read Replies (3) | Respond to of 32384
 
Ligand continues to disappoint in the price appreciation area, but based on the quarterly and yearly earnings report, I think I see a glimmer of hope. The consensus numbers from the analysts was a loss of .21 cents for the quarter and 1.21 loss for the year. The actual numbers being a .09 cent loss for the Q and 1.06 loss for the year are certainly impressive to me.Maybe there is hope for my Feb. 12.50 calls.



To: tonyt who wrote (14334)2/6/1998 10:36:00 AM
From: Flagrante Delictu  Respond to of 32384
 
tonyt, If you get a chance, please read Stewart H. Whitman's informative post #14334. It might help clarify the issue for you. A Nobel prize in Economics was awarded to Fisher Black for supplying the Black-Scholes model enabling the valuation analysis of underlying instruments vis-a-vis their derivatives. When that model was used by Stewart H. Whitman in order to find out what the model indicated LGNDW's fair value, on a risk neutral basis, was compared to LGND, when LGND was trading at $11.31 the other day, the answer given was $6.00. You , at the same time were saying that LGNDW was worth only $5.25. To justify your faulty conclusion, you pointed out that ownership of the warrants instead of the stock, when the warrants were $6.00 & the stock was $11.31, came at a cost of 14% in interest. However, that did not take into account the risk that the stock could decline $5.31 more than the warrants. The Black-Scholes model, on the other hand is risk neutral between these instruments, and assumed the risk-free rate of return of 6% based upon where the 2 year Treasuries were trading. Nor did you take into account that the trader could margin the warrants. You assumed only margining the stock. Since some traders might not have available the additional funds, you made no allowance for their preference to be positioned in the stock via the warrants. For these reasons, I pointed out that your analysis was flawed. In the face of the Nobel prize winning analysis to the contrary, you persist in espousing this drivel, which you think enables you to escape answering the many questions which have arisen from the disturbing posts you have foisted upon us. Bernie.